On Monday, Coeptis Therapeutics Holdings Inc (NASDAQ: COEP) opened higher 6.02% from the last session, before settling in for the closing price of $0.21. Price fluctuations for COEP have ranged from $0.15 to $1.38 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -20.00% annually for the last half of the decade. With a float of $28.42 million, this company’s outstanding shares have now reached $35.33 million.
In an organization with 7 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 33.35%, operating margin of -1128.46%, and the pretax margin is -1068.89%.
Coeptis Therapeutics Holdings Inc (COEP) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Coeptis Therapeutics Holdings Inc is 28.89%, while institutional ownership is 4.17%. The most recent insider transaction that took place on Jan 10 ’24, was worth 3,350. In this transaction Chief Financial Officer of this company bought 5,000 shares at a rate of $0.67, taking the stock ownership to the 30,000 shares. Before that another transaction happened on Jan 12 ’24, when Company’s Director bought 2,266 for $0.58, making the entire transaction worth $1,305. This insider now owns 32,266 shares in total.
Coeptis Therapeutics Holdings Inc (COEP) Latest Financial update
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.39 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.28) by -0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
Coeptis Therapeutics Holdings Inc (NASDAQ: COEP) Trading Performance Indicators
Check out the current performance indicators for Coeptis Therapeutics Holdings Inc (COEP). In the past quarter, the stock posted a quick ratio of 0.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51
Technical Analysis of Coeptis Therapeutics Holdings Inc (COEP)
Let’s dig in a bit further. During the last 5-days, its volume was 0.36 million. That was better than the volume of 0.32 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 87.04%. Additionally, its Average True Range was 0.02.
During the past 100 days, Coeptis Therapeutics Holdings Inc’s (COEP) raw stochastic average was set at 36.57%, which indicates a significant decrease from 88.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.22% in the past 14 days, which was lower than the 68.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1897, while its 200-day Moving Average is $0.3310. However, in the short run, Coeptis Therapeutics Holdings Inc’s stock first resistance to watch stands at $0.2346. Second resistance stands at $0.2473. The third major resistance level sits at $0.2645. If the price goes on to break the first support level at $0.2047, it is likely to go to the next support level at $0.1875. The third support level lies at $0.1748 if the price breaches the second support level.
Coeptis Therapeutics Holdings Inc (NASDAQ: COEP) Key Stats
There are currently 37,119K shares outstanding in the company with a market cap of 8.87 million. Presently, the company’s annual sales total 0 K according to its annual income of -21,270 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -3,040 K.
